Researchers discover a way to increase the effectiveness of antibiotics
A multi-disciplinary project driven by EMBL Australia researchers at Monash University and Harvard University has found a way to make antibiotics more effective against antibiotic-resistant bacteria - also known as ‘superbugs.
IP Group and Monash University invest $1.5 million into Inosi Therapeutics
Awarded $704K funding from TTRA to accelerate treatment of fibrosis
Monash researchers link protein to oxidative stress and related diseases
Scientists at Monash University’s Biomedicine Discovery Institute (BDI) have discovered a new role for a known protein in oxidative stress, which is linked to diseases such as Alzheimer’s and Parkinson’s, diabetes, cardiovascular
Study challenges popular jaw surgery technique
Research led by the Monash Biomedicine Discovery Institute (BDI) has found the technique currently used in clinics to fix a broken jaw is not biomechanically stable.
Untangling the heart’s genome: now in 3D
Research led by Australian Regenerative Medicine Institute and Monash Biomedicine Discovery Institute (BDI) researchers at Monash University has combined cutting-edge genomics and 3D “gaming” modelling to understand how all genes
Cardiovascular health - matters of the heart
Monash is bringing together world-leading experts to tackle heart disease and develop game-changing treatment options and technologies.
Monash University researchers unlock the key that could lead to the development of non-opioid painkillers to treat chronic pain
Monash University researchers have made a breakthrough discovery that could pave the way for the development of novel non-opioid painkillers (analgesics) to safely and effectively treat neuropathic pain.
Monash BDI researcher a Eureka finalist
Congratulations to Associate Professor Fasseli Coulibaly from the Monash Biomedicine Discovery Institute who, as part of Team Chimera - in collaboration with University of Queensland and QIMR Berghofer Medical Research Institute researchers, has